Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

FDA Panel Backs Female Libido Drug

By Drug Discovery Trends Editor | June 5, 2015

(AP Photo/Allen G. Breed)On Thursday, the panel of advisers to the U.S. Food and Drug Administration voted 18 to 6 to recommend that the agency approve flibanserin— nicknamed ‘women’s Viagra’ — as the first prescription treatment to boost libido in women. The contingency? That the drug’s manufacturer, Sprout Pharmaceutical, develops measures to limit safety risks. Flibanserin’s risks include low blood pressure and fainting.

“I have serious, serious, serious safety concerns,” said Dr. Walid Gellad of the University of Pittsburgh, a panel member who still voted to recommend approval, reports NBC News. “The benefits are modest, maybe less than modest. But I think that puts it in good company with other approved drugs.”

Flibanserin, a pink pill that would be taken daily at bedtime, would be approved to treat hypoactive sexual desire disorder.

The positive recommendation is a major victory for a drug that’s been twice rejected by the FDA since 2010 due to its minimal benefits and safety concerns. 


Filed Under: Drug Discovery

 

Related Articles Read More >

Pharmacovigilance
A new era of pharmacovigilance: Worldwide master key for drug safety monitoring
Takeda Pharmaceutical in the Drug Discovery & Development Pharma 50
Takeda’s Takhzyro fares well in pediatric hereditary angioedema study
Novartis in the Pharma 50
Novartis to cut up to 8,000 positions
Gilead Sciences in the Drug Discovery & Development Pharma 50
Gilead resubmits application to FDA for twice-yearly HIV drug lenacapavir

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50